175
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of 1% terbinafine cream in comparison with 0.75% metronidazole gel for the treatment of papulopustular rosacea

&
Pages 124-128 | Received 15 Oct 2010, Accepted 16 Nov 2010, Published online: 20 Dec 2010

References

  • Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994, 130, 359–362.
  • Döring HF, Ilgner M. [Therapy of rosacea with bifonazole cream–practical experiences over a 2-year period]. Z Hautkr 1986, 61, 490–494.
  • Utaş S, Ünver Ü. Treatment of rosacea with ketoconazole. J Eur Acad Dermatol Venerol 1997, 8, 69–70.
  • Nielsen PG. Treatment of rosacea with 1% metronidazole cream. A double-blind study. Br J Dermatol 1983, 108, 327–332.
  • Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 1986, 114, 231–234.
  • Grove DI, Mahmound AA, Warren KS. Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol 1977, 54, 422–427.
  • Choczaj-Kukula A, Kwasniewska J. [Current possibilities of using antimycotic drugs in the treatment of various skin disorders]. Wiad Parazytol 2004, 50, 125–133.
  • Camera E, Cannistraci C, Briganti S, Colombo D, Picardo M. Scavenging effects of terbinafine on free radicals in vitro. Br J Dermatol 1999, 140, 640–644.
  • Sander CS, Hipler UC, Wollina U, Elsner P. Inhibitory effect of terbinafine on reactive oxygen species (ROS) generation by Candida albicans. Mycoses 2002, 45, 152–155.
  • Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol 1997, 36, 788–792.
  • Rashid A, Williams TG. Oral Terbinafine in the Treatment of Rosacea. Poster at Annual Meeting of the AAD 2001.
  • Jiflu M, Neamtu S. Terbinafine, modality of treatment in rosacea. J Eur Acad Dermatol Venereol 2003, 17, 165–426.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.